4 free views remaining today

peripheral nerve sheath neoplasm

Description

Peripheral Nerve Sheath Neoplasms: An Overview

Peripheral nerve sheath neoplasms, also known as peripheral nerve tumors or malignant peripheral nerve sheath tumors (MPNSTs), are a type of tumor that develops in the nerves outside of the central nervous system (brain and spinal cord). These neoplasms can be either benign or malignant.

Types of Peripheral Nerve Sheath Neoplasms

  • Benign: Most cases of peripheral nerve sheath tumors are benign, with schwannomas and neurofibromas being the most common types. These tumors are usually slow-growing and do not spread to other parts of the body.
  • Malignant: Malignant peripheral nerve sheath tumors (MPNSTs) are a type of cancer that begins in the layer covering the peripheral nerves. They can be aggressive and have a tendency to metastasize.

Causes and Risk Factors

  • Genetic conditions: MPNSTs often occur in people with neurofibromatosis 1 (NF1), NF2, or schwannomatosis, which are characterized by multiple nerve sheath tumors.
  • Radiation exposure: People who have been exposed to radiation are at a higher risk of developing peripheral nerve tumors years later.

Symptoms and Complications

  • Numbness and weakness: Peripheral nerve tumors can press against nerves, leading to numbness and weakness in the affected area.
  • Loss of function: In severe cases, loss of function in the affected area may occur.
  • Trouble with balance: Balance problems can also be a symptom of peripheral nerve tumors.

Treatment Options

  • Surgery: Surgery is often necessary to remove the tumor. Depending on the location and size of the tumor, surgically removing the arm or leg might be required.
  • Radiation therapy: Radiation before surgery may shrink the tumor, making it more likely that all of the tumor is removed.

Incidence and Demographics

  • Rare condition: Peripheral nerve tumors are relatively rare, with most cases being sporadic and their cause unknown.
  • Age and sex: MPNSTs typically affect people aged 30 to 50. Men are slightly more likely to develop this condition than women.

References:

[1] Context result 12 [2] Context result 4 [3] Context result 6 [4] Context result 10 [5] Context result 14

Additional Characteristics

  • Schwannomatosis
  • Neurofibromas
  • Schwannomas
  • Malignant peripheral nerve sheath tumors (MPNSTs)
  • Peripheral nerve sheath neoplasms
  • Neurofibromatosis 1 (NF1)
  • Neurofibromatosis 2 (NF2)
  • Radiation exposure

Signs and Symptoms

Common Signs and Symptoms of Peripheral Nerve Sheath Neoplasms

Peripheral nerve sheath neoplasms, also known as peripheral nerve tumors, can cause a variety of symptoms depending on their location and size. Here are some common signs and symptoms associated with these neoplasms:

  • Pain: Pain is the most common symptom of peripheral nerve sheath neoplasms, occurring in about 70-80% of cases [4]. The pain can be constant or intermittent, and may worsen over time as the tumor grows.
  • Numbness, Tingling, or Weakness: Nerve compression or damage caused by the tumor can lead to numbness, tingling, or weakness in the affected area [3].
  • Lump or Swelling: A palpable lump or swelling under the skin may be noticed as the tumor grows [4].
  • Changes in Sensitivity: Changes in sensitivity to touch, temperature, or pain may occur due to nerve compression or damage [7].
  • Weakness: Weakness in a particular area or muscle group may be experienced due to nerve compression or damage [8].

Other Possible Symptoms

In some cases, peripheral nerve sheath neoplasms may also cause:

  • Changes in Reflexes: Changes in reflexes, such as decreased or absent reflexes, may occur due to nerve compression or damage.
  • Muscle Atrophy: Muscle atrophy or wasting may occur if the tumor compresses or damages nerves that control muscle function.

Symptom Presentation

It's worth noting that some people with peripheral nerve sheath neoplasms may not experience any symptoms at all, especially in the early stages of the disease [5]. In these cases, the tumor may be discovered incidentally during imaging studies for unrelated reasons.

Diagnostic Tests

Treatment

Treatment Options for Peripheral Nerve Sheath Neoplasms

Peripheral nerve sheath neoplasms, also known as malignant peripheral nerve sheath tumors (MPNSTs), are aggressive soft tissue sarcomas that can be challenging to treat. While surgery is often the primary treatment option, drug therapy may also play a role in managing these tumors.

Combination Therapy

Research suggests that combining two experimental drugs may help treat MPNSTs with fewer harmful side effects [1]. This approach involves using a MEK inhibitor (selumetinib) and an anthracycline-based treatment to target the tumor cells. Studies have shown promising results, but more research is needed to confirm the efficacy of this combination therapy.

Targeted Cancer Drugs

Targeted cancer drugs, such as chemotherapy and hormone therapy, may also be used to treat MPNSTs [8]. These treatments work by interfering with cell growth and replication, making it difficult for the tumor cells to multiply. However, the effectiveness of these treatments can vary depending on the individual case.

Treatment Challenges

MPNSTs are often resistant to traditional chemotherapy and radiation therapy, making treatment challenging [9][10]. The tumors may also develop resistance to targeted cancer drugs over time, requiring alternative treatment approaches.

Current Research

Researchers at the Johns Hopkins Kimmel Cancer Center are exploring new combination therapies for MPNSTs, including a pair of experimental drugs that show promise in preliminary animal studies [1][7].

Summary

In summary, while surgery is often the primary treatment option for peripheral nerve sheath neoplasms, drug therapy may also play a role in managing these tumors. Combination therapy with MEK inhibitors and anthracycline-based treatments shows promise, but more research is needed to confirm its efficacy.

References:

[1] Dec 1, 2023 — Combining a pair of experimental drugs may help treat malignant peripheral nerve sheath tumors with fewer harmful side effects, according to preliminary animal studies led by investigators at the Johns Hopkins Kimmel Cancer Center and Johns Hopkins Drug Discovery. [7]

[8] Treatment for cancer. Treatments can include surgery, radiotherapy and drug treatments (such as chemotherapy, hormone therapy or targeted cancer drugs). Find ... [8]

[9] Jan 31, 2024 — A combination of two cancer drugs could be effective against malignant peripheral nerve sheath tumors (MPNSTs) -; soft tissue tumors that are stubbornly resistant to chemotherapy and radiation — according to a laboratory study led by researchers at the Johns Hopkins Kimmel Cancer Center. [9]

[10] A combination of two cancer drugs could be effective against malignant peripheral nerve sheath tumors (MPNSTs) — soft tissue tumors that are stubbornly resistant to chemotherapy and radiation — according to a laboratory study led by researchers at the Johns Hopkins Kimmel Cancer Center.. Both drugs interfere with cell growth and replication but have different mechanisms of action. [10]

Recommended Medications

  • chemotherapy
  • hormone therapy
  • anthracycline-based treatment
  • targeted cancer drugs
  • inhibitor

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis of peripheral nerve sheath tumors (PNSTs) is a crucial aspect of their evaluation, as it helps to distinguish them from other types of neoplasms that may present with similar characteristics. Based on the search results, here are some key points to consider:

  • Neurofibroma: This is a type of benign PNST that can be difficult to differentiate from schwannoma and perineurioma (1). Diagnostic criteria for neurofibroma include the presence of a well-circumscribed mass with a characteristic "honeycomb" appearance on imaging studies (1).
  • Schwannoma: Also known as neurilemmoma, this is a benign PNST that can be distinguished from other types of nerve sheath tumors by its pure population of Schwann cells (14). Schwannomas are typically well-circumscribed and may exhibit a characteristic "target" appearance on imaging studies.
  • Perineurioma: This is a rare type of PNST that can be difficult to differentiate from neurofibroma and schwannoma (1).
  • Malignant peripheral nerve sheath tumors (MPNST): These are rare and aggressive neoplasms that can be challenging to diagnose, especially in their early stages. MPNSTs may present with a range of imaging characteristics, including a well-circumscribed mass or a more infiltrative pattern (3).
  • Other differential diagnoses: Other types of neoplasms that should be considered in the differential diagnosis of PNSTs include tenosynovial giant cell tumor, angioleiomyoma, hemangioma, benign and malignant myxoid tumors, such as myxoid liposarcoma (2), synovial sarcoma, fibrosarcoma, undifferentiated pleomorphic sarcoma, angiosarcoma, and nerve sheath myxoma and neurothekeoma (5, 10).

In terms of diagnostic criteria, the following points are worth noting:

  • Imaging studies: Imaging studies, such as MRI or CT scans, can be helpful in evaluating PNSTs and distinguishing them from other types of neoplasms. However, imaging characteristics alone may not be sufficient to make a definitive diagnosis (3).
  • Histopathological examination: Histopathological examination of tissue samples is often necessary to confirm the diagnosis of a PNST. This involves examining the morphology and immunohistochemical properties of the tumor cells (9).

Overall, the differential diagnosis of PNSTs requires a comprehensive evaluation of clinical, imaging, and histopathological findings. A thorough understanding of the diagnostic criteria for each type of PNST is essential to ensure accurate diagnosis and treatment.

References:

(1) Search result 1 (2) Search result 2 (3) Search result 3 (4) Search result 4 (5) Search result 5 (9) Search result 9 (10) Search result 10 (14) Search result 14

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasDbXref
UMLS_CUI:C0751689
oboInOwl#id
DOID:3193
core#notation
DOID:3193
IAO_0000115
A peripheral nervous system neoplasm that is located in the connective tissue surrounding nerves.
oboInOwl#hasExactSynonym
nerve sheath tumour
rdf-schema#label
peripheral nerve sheath neoplasm
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_cancer_slim
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_4697
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_10186
owl#annotatedSource
t423036

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.